ImmunologybioRxivPreprint
RIPK3-RNASE1 axis as a potential therapeutic and clinical monitoring target in VEXAS syndrome
Kana Higashitani, Tatsuma Ban, Yohei Kirino…·Tomohiko Tamura
This study identifies the RIPK3-RNASE1 axis as a potential biomarker and therapeutic target in VEXAS syndrome by linking genetic mutations to disease activity and pathological features.